Superluminal Medicines, Inc., 2026-09-03
A new SEC Form D private-offering notice from Boston, MA, a $65,480,796 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Biotech developing small molecule GPCR-targeted therapeutics for cardiometabolic and endocrine diseases using an AI-driven drug discovery platform
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Animal Biosciences, Inc., 2026-09-09, $2.6M, Boston, MA
- JUPITER NEUROSCIENCES, INC., 2026-09-04, $775K, Palm Beach Gardens, FL
- Sonagram Inc., 2026-09-08, $1M, Stoughton, MA
- Immunophotonics, Inc., 2026-09-04, St. Louis, MO
- Sute Media Inc., 2026-09-04, $1M, Watertown, MA
- Pluri Inc., 2026-09-04, $3.7M, Haifa
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.